News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Sanofi (France) (SAN.PA), Emcure Pharmaceuticals Limited Ink Marketing Pact For Cancer Drugs



8/6/2014 5:56:21 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Sanofi India Ltd. announced that it has entered into a marketing and distribution agreement with Emcure Pharmaceuticals for its oncology portfolio in India.

Under the agreement terms, while Sanofi will continue to own its oncology range, comprising 4 brands namely Taxotere, Jevtana, Fludara and Fasturtec, Emcure will market and distribute these brands through its Specialty Unit.

Commenting on the partnership, Shailesh Ayyangar, Vice President -South Asia and Managing Director -Sanofi India and Sanofi -Synthelabo (India) Ltd. said, "Sanofi is highly committed to the field of Oncology.

Help employers find you! Check out all the jobs and post your resume.

Read at RTT News
Read at Live Mint
Read at Times of India
Read at CNBC


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES